Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISER2: Viramidine vs Ribavirin in Chronic Hepatitis C
NCT00093093Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2004
- Primary completion
- May 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 12
01
Overview
A Phase 3 trial of taribavirin in hepatitis C (HCV), sponsored by Valeant Pharmaceuticals. Started Jun 2004; status: completed.
02
Drugs
taribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00093093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093093.